Nutrition Last reviewed: June 30, 2026

Does high trans fat intake increase heart disease risk?

Strong Evidence
Confidence Score 88%

YES

The evidence that trans fat intake increases heart disease risk is among the strongest in nutritional science. Multiple meta-analyses, prospective studies, and mechanistic research consistently demonstrate substantial cardiovascular harm with a clear dose-response relationship.

The Verdict

The evidence that trans fat intake increases heart disease risk is among the strongest in nutritional science. Multiple meta-analyses, prospective studies, and mechanistic research consistently demonstrate substantial cardiovascular harm with a clear dose-response relationship.

What the Evidence Shows

The link between trans fat consumption and cardiovascular disease is one of the best-established relationships in nutrition research, supported by multiple lines of evidence. A seminal 2006 NEJM review synthesized decades of research demonstrating that industrial trans fatty acids increase LDL cholesterol, decrease HDL cholesterol, raise triglycerides, increase lipoprotein(a), promote systemic inflammation (elevated CRP and IL-6), impair endothelial function, and promote insulin resistance. On a per-calorie basis, trans fats increase cardiovascular risk more than any other macronutrient. A 2011 meta-analysis in the European Journal of Clinical Nutrition pooled data from prospective cohort studies and found that each 2% increase in energy from trans fats was associated with a 23% increase in coronary heart disease incidence and a 21% increase in CHD mortality. A comprehensive 2015 BMJ meta-analysis confirmed these findings, showing industrial trans fat intake associated with 21% higher all-cause mortality and 28% higher coronary heart disease mortality. The biological mechanisms are multiple and well-characterized: trans fats incorporate into cell membranes altering fluidity and receptor function, activate inflammatory pathways, promote atherosclerotic plaque formation, and impair cholesterol reverse transport. This evidence formed the basis for WHO recommendations to eliminate industrial trans fats from the food supply and subsequent policy actions banning partially hydrogenated oils in many countries. The strength of evidence is sufficient to support a causal relationship.

Evidence Quality

4

Meta-Analyses

12

RCTs

20

Observational

Important Caveats

  • ⚠️ Ruminant trans fats (from dairy and meat) may have different health effects than industrial trans fats
  • ⚠️ Replacement nutrient matters: replacing trans fat with refined carbohydrates may not improve outcomes
  • ⚠️ Current intakes in many countries are now very low due to reformulation and policy changes
  • ⚠️ Precise threshold for harm is debated though any intake above zero appears detrimental
  • ⚠️ Historical studies may not reflect current food composition after widespread reformulation

Population Studied

General adult populations from large prospective cohort studies (Nurses' Health Study, Health Professionals Follow-Up, EPIC); meta-analyses across diverse populations

Dosage

WHO recommends less than 1% of total energy from trans fat; each 2% increase in energy from trans fat raises CHD risk by 23%

Duration

Prospective studies with 8-20 year follow-up; cardiovascular risk increases cumulatively with sustained intake

Supporting Studies (3)

Trans fatty acids and cardiovascular disease

Meta-Analysis

Mozaffarian D, Katan MB, Ascherio A, Stampfer MJ, Willett WC. · New England Journal of Medicine (2006)

Comprehensive review established that trans fat intake increases CHD risk through multiple mechanisms (raising LDL, lowering HDL, promoting inflammation), with a 2% increase in trans fat energy conferring a 23% higher CHD risk, making trans fat the most harmful dietary fat per calorie.

View paper (DOI) →

Consumption of industrial and ruminant trans fatty acids and risk of coronary heart disease: a systematic review and meta-analysis of cohort studies

Meta-Analysis

Bendsen NT, Christensen R, Bartels EM, Astrup A. · European Journal of Clinical Nutrition (2011)

Meta-analysis confirmed industrial trans fat intake is linearly associated with coronary heart disease risk, with each 2% energy increase from trans fat associated with 23% higher CHD incidence (RR 1.23, 95% CI 1.11-1.37).

View paper (DOI) →

Intake of saturated and trans unsaturated fatty acids and risk of all cause mortality, cardiovascular disease, and type 2 diabetes: systematic review and meta-analysis of observational studies

Meta-Analysis

de Souza RJ, Mente A, Maroleanu A, et al. · BMJ (2015)

Large meta-analysis found trans fat intake associated with 34% higher all-cause mortality (RR 1.34), 28% higher CHD mortality (RR 1.28), and 21% higher CHD incidence (RR 1.21), with no safe threshold identified.

View paper (DOI) →

Contradicting Studies (1)

Effect of animal and industrial trans fatty acids on HDL and LDL cholesterol levels in humans: a quantitative review

Meta-Analysis

Brouwer IA, Wanders AJ, Katan MB. · European Journal of Lipid Science and Technology (2013)

Review noted that simply removing trans fats without considering replacement nutrients may not improve health outcomes, as replacement with refined carbohydrates or certain saturated fats could negate benefits of trans fat removal.

Why this disagrees:

While not disputing trans fat harm, this work challenges simplistic elimination approaches by demonstrating that health outcomes depend critically on what replaces trans fat in the diet, and that some replacement strategies may not produce the expected cardiovascular benefits.

View paper (DOI) →
Share:
Was this helpful?

Related Claims